PeptadexPEPTADEX
Back to Library

Modified GRF (1-29)

Also known as: Mod GRF, CJC-1295 without DAC

Growth HormonePHASE 2

Clinical Status

Investigational — research compound widely used in combination protocols.

Mechanism of Action

Modified version of the first 29 amino acids of GHRH with amino acid substitutions at positions 2, 8, 15, and 27 to resist enzymatic degradation. Stimulates pituitary GH release with improved stability over native GHRH.

Dosing Defaults

Dose

100-200 mcg

Frequency

2-3x daily

Administration

Subcutaneous injection

Timing

Before bed or morning (fasted)

Food

fasted

Duration

8-12 weeks

Dose range: 100-300 mcg per dose

Best combined with a GHRP at the same time. Fasted state maximizes GH pulse.

Side Effects

  • •Facial flushing
  • •Injection site reactions
  • •Headache
  • •Dizziness
  • •Water retention

Contraindications & Warnings

  • ⚠Active malignancy
  • •Not medical advice

Compare

Compare Modified GRF (1-29) with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Modified GRF (1-29) dose.

Open Calculator

Ad

Related Growth Hormone Peptides

Ipamorelin

PHASE 2
Growth Hormone

Selective GH secretagogue. Considered one of the safest GHRPs.

CJC-1295

PHASE 2
Growth Hormone

Synthetic GHRH analog that stimulates GH release from the pituitary.

CJC-1295 DAC

PHASE 2
Growth Hormone

Long-acting version of CJC-1295 with extended half-life via albumin binding.

Tesamorelin

FDA APPROVED
Growth Hormone

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.